Atlas Trials

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

Clinical trial NCT01708044 · COMPLETED

Trial details

NCT number
NCT01708044
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 1 Diabetes
Start date
2012-11-01
Primary completion
2013-09-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.